GlassScriptPhysician profile
Jason Gregory Cundiff
NPI 1053325233
$6,084.73
in general payments reported to CMS, 2019-2025
24 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $956 · 2021: $809 · 2022: $1,782 · 2023: $389 · 2024: $468 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,058.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,364.72 | 2020-2025 | Inspire |
| Medical Device Business Services, INC. | $1,307.52 | 2022 | |
| Optinose US, INC. | $681.24 | 2019-2025 | |
| Stryker Corporation | $471.66 | 2019-2025 | Scopis Ent |
| Aerin Medical INC. | $408.59 | 2019-2025 | |
| Acclarent, INC | $275.53 | 2019-2023 | Relieva Spinplus, Trudi Nav Cable |
| Cochlear Americas | $260.07 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Integra Lifesciences Corporation | $165.92 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Olympus America INC. | $141.86 | 2025 | Rhino-Laryngo Videoscope |
| Genzyme Corporation | $135.05 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $126.82 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $119.61 | 2021-2025 | Nucala |
| Medtronic USA, INC. | $102.92 | 2019-2020 | |
| Intersect Ent, INC. | $92.36 | 2019-2020 | |
| Medtronic, INC. | $71.58 | 2021-2025 | Propel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $69.95 | 2020-2025 | Grastek, Ragwitek, Odactra |
| Smith+Nephew, INC. | $64.93 | 2019-2023 | Coblation, Tula |
| Neurent Medical Limited | $61.62 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Livanova USA, INC. | $41.22 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Paratek Pharmaceuticals, INC. | $40.10 | 2025 | Xhance |
| Csl Behring | $28.21 | 2023 | Kcentra, Haegarda |
| Kaleo, INC. | $19.41 | 2023 | Auvi-Q |
| Amgen INC. | $18.72 | 2024 | Tezspire |
| Biotissue Holdings INC. | $15.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cundiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.